Research
Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia
-
* Corresponding authors: Iain J Gallagher iaingallagher@ed.ac.uk - James A Timmons Jamie.Timmons@gmail.com
- † Equal contributors
1 Department of Clinical and Surgical Sciences (Surgery), School of Clinical Sciences and Community Health, University of Edinburgh, EH16 4SB, UK
2 Translational Biomedicine, Heriot-Watt University, Edinburgh, EH14 4AS, UK
3 Department of Anaesthesiology and Intensive Care, and Department of Surgery, Karolinska University Hospital, 14186, Huddinge, Sweden
4 Department of Biology and Biotech Research and Innovation Centre, Ole Maaloes Vej 5, University of Copenhagen, DK-2200, Denmark
5 Division of Human Cancer Genetics, Ohio State University Medical Center, Columbus, OH 43210, USA
6 Lifestyle Research Group, The Royal Veterinary College, 4 Royal College Street, University of London, NW1 0TU, UK
7 Centre for Healthy Ageing, Department of Biomedical Sciences, University of Copenhagen, Blegdamsvej, DK-2200, Denmark
Genome Medicine 2010, 2:1 doi:10.1186/gm122
Published: 15 January 2010Additional files
Additional file 1:
Primers used in the study, genes associated with systemic inflammation and data on autophagy pathway genes.
Format: DOC Size: 37KB Download file
This file can be viewed with: Microsoft Word Viewer
Additional file 2:
Genes associated with weight loss or systemic inflammation in cancer cachexia.
Format: XLS Size: 74KB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 3:
Figures and figure legends for supplementary figures referred to in the text.
Format: PPT Size: 761KB Download file
This file can be viewed with: Microsoft PowerPoint Viewer